Deucravacitinib
bms
['psoriasis', 'bms', 'scienceatbms']
attend our presentation this saturday at #eadvcongress to explore the long-term efficacy with a continuous, once-daily treatment in plaque #psoriasis.
Official Bristol Myers Squibb Twitter handle for science. Connecting researchers, scientists and healthcare professionals through science; guidelines below: